Cognitive Decline Is Now Optional: Here’s Why
Summary
- Neurodegenerative diseases like Alzheimer’s have been a significant area of biomedical therapeutic failure, but new research is changing this narrative
- Alzheimer’s is seen as a network insufficiency, and treating it requires identifying and addressing multiple potential contributors
- This approach led to the first reversals of cognitive decline in patients with Alzheimer’s or pre-Alzheimer’s, marking a significant breakthrough in the field
- This video is part of the Multiple Sclerosis and Neuroimmune Summit
